Related Experiment Videos
Platyspondyly in treated beta-thalassemia
C Orzincolo1, G Castaldi, P N Scutellari
1Department of Radiology, St. Anna Hospital, Ferrara, Italy.
European Journal of Radiology
|May 1, 1994
Summary
Patients with thalassemia major on intensive transfusion therapy showed vertebral body flattening (platyspondyly). This may result from suppressed blood cell production, leading to reduced vertebral height under normal stresses.
Area of Science:
- Pediatric Endocrinology
- Hematology
- Radiology
Background:
- Thalassemia major patients often undergo intensive transfusion regimens and chelation therapy.
- Short stature is a common concern in children with thalassemia major.
- Vertebral abnormalities can impact growth and development.
Purpose of the Study:
- To investigate the prevalence and characteristics of vertebral body flattening in thalassemia major patients.
- To explore the potential relationship between intensive transfusion therapy and vertebral changes.
Main Methods:
- Retrospective evaluation of 14 thalassemia major patients with short stature.
- Analysis of vertebral body height/width ratios across cervical, dorsal, and lumbar spine.
- Comparison with a larger cohort of 106 thalassemia major patients.
Main Results:
- Platyspondyly (flattening of vertebral bodies) was observed in 14 patients.
- Reduced vertebral body height/width ratio was noted in all investigated spinal regions.
- This finding was associated with intensive transfusion and chelation therapy.
Conclusions:
- Intensive transfusion regimens in thalassemia major may lead to vertebral body flattening.
- Suppressed intramedullary hematopoiesis and altered intravertebral pressure are potential contributing factors.
- Vertebral flattening could be a consequence of biological and mechanical stresses on altered bone structure.